Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Tesamorelin structure

Tesamorelin

Growth Hormone
Approved Research
90%
Low Risk
1/5

Warnings

Contraindicated with active malignancy
May affect glucose tolerance
Monitor IGF-1 levels

Contraindications

PregnancyBreastfeedingActive CancerPituitary TumorsHypersensitivity To Tesamorelin

Drug Interactions

GlucocorticoidsInsulinOral Contraceptives

Possible Side Effects

Injection Site ReactionsArthralgiaPeripheral EdemaMyalgia

Legal & Regulatory

FDA Status FDA Approved
WADA Status Prohibited in Sport
Approved In USA, Canada
Prescription Required

Pregnancy

Category X - Contraindicated